About DermaFlow

Non-invasive peripheral blood flow measurement opens new horizons for the clinician, patient, in and out of hospital, and the consumer.

Peripheral blood flow changes are amongst the very first to occur in acute and chronic medical situations, such as multi-organ dysfunction, sepsis, shock, vascular insufficiencies (Peripheral Artery Disease or PAD) and cardiovascular distress (Congestive Heart Failure, Coronary Arterial Disease).

Peripheral blood flow changes are also associated with multiple healing processes following skin, muscle and soft tissue damage, such as diabetic ulcers and neuropathy, and sports injuries.

Many disease states influence peripheral blood flow, either directly or indirectly. DermaFlow technology can accurately track these changes, allowing the clinician to monitor the patient, giving early feedback of change in disease status.

For doctors’ clinics, Dermaflow technology could simplify the process of screening for peripheral artery disease. Those with previously diagnosed peripheral artery disease  - or  those with a sedentary lifestyle - may find the technology useful in monitoring the state of  lower limb blood supply as well as helping to improve quality of life by improving compromised mobility

DermaFlow technology – a new dimension in active wearable, bedside and integrated health care devices

THE DERMAVASC™ CONCEPT – LOWER LIMB PERIPHERAL PERFUSION: A WINDOW INTO PERIPHERAL ARTERY DISEASE

The DermaVasc concept is based on combining  transcutaneous electrical nerve stimulation (TENS) and DermaFlow peripheral blood flow measuring technology into one wearable product.

Changes in lower limb peripheral blood flow following TENS stimulation can be measured using DermaFlow  technology.Early work has shown these changes are associated with varying severities of symptomatic  and asymptomatic PAD as well as non-PAD affected limbs.

DermaFlow has patented the use of the combination of the two technologies for the user at home either to monitor status of diagnosed PAD, to check on lower limb peripheral circulation (especially for high risk individuals, including the sedentary population and diabetics) or for the healthcare professionals, in particular the primary care physician and podiatrist, to rapidly identify PAD at all stages of the disease.

The advantages of low cost, user-friendliness, accuracy, optimal sensitivity and ability to embed suggest that the Perichek™ module designed for integration into hospital patient monitoring suites be considered as a first line technology for both clinical and consumer applications.

perichek™

The Perichek™ peripheral blood flow module features thermally based DermaFlow technology providing a non-invasive, direct, accurate, and sensitive, method for measuring changes in peripheral blood flow.